Clinical characteristics, treatment, and outcomes of Oxaliplatin-induced immune thrombocytopenia - Poll - MDSpire

Clinical characteristics, treatment, and outcomes of Oxaliplatin-induced immune thrombocytopenia

  • By

  • Nan Huang

  • Zheng Liu

  • Ronghui Li

  • Haibo Lei

  • Xiang Liu

  • May 14, 2026

  • 0 min

Share

Original Source(s)

Clinical characteristics, treatment, and outcomes of Oxaliplatin-induced immune thrombocytopenia

  • by Nan Huang, Zheng Liu, Ronghui Li, Haibo Lei, Xiang Liu

  • May 14, 2026

Related Content

Changes in dietary habits following a colon cancer diagnosis: insights from the prospective ECHO (Eating habits CHanges in Oncologic patients) STUDY 2.0

Organ-specific pre-metastatic and metastatic niches in colorectal cancer: “discrepancy in response to immune checkpoint inhibitors in liver and lung metastasis”

Integrated perspectives on colorectal carcinogenesis: molecular pathogenesis, genomic alterations, diagnostic paradigms, therapeutic interventions and AI–driven directions in precision oncology